A new peer-reviewed study has found that gentle electrical stimulation of vagus and trigeminal nerve branches in/around the ...
The Wasteful and Inappropriate Service Reduction model is being piloted in six states, requiring Medicare recipients to seek ...
Last week, I added a new item to my already wide armoury of sleep aids. As well as my ear plugs and my eye mask, I was given ...
Global Pain Management Devices Market OverviewThe global pain management devices market is projected to register a compound annual growth rate (CAGR) of approximately 9% over the forecast period.
A wrist-worn, AI-driven transcutaneous peripheral nerve stimulator is linked to greater improvement in patients with ...
The new rates reflect a 12% to 15.8% rise over current copays for medications purchased at retail pharmacies and through the ...
AI-driven nerve stimulation shows significant improvement in essential tremor symptoms, offering a noninvasive treatment ...
A mother who has lived with daily chronic back pain for over a decade has described a new pain management group inMare ...
Medical Device Network on MSN
FDA clears NeurAxis’ neurostimulator for abdominal pain
The expanded FDA clearance makes NeurAxis’ IB-Stim the first FDA approval for a treatment that specifically addresses ...
Neuraxis Inc (NASDAQ:NRIX) stock gained 4.2% in premarket trading Friday after the company received FDA clearance for its nerve stimulation technology to treat functional abdominal pain. The U.S. Food ...
Achieves significant expansion of NeurAxis’ total addressable marketClearance now includes patients aged “8 years and older”Expanded age indication will utilize the upcoming January 1st, 2026, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback